The subcutaneous route involves depositing medication into the loose connective tissue layer situated directly beneath the dermis and above the muscle layer. Because this tissue has fewer blood vessels compared to muscle, drug absorption is notably slower and more sustained, making it ideal for medications like insulin and low molecular weight heparins. Nurses must understand that subcutaneous fat is not uniformly distributed across the body, meaning body habitus directly influences how an injection is delivered.
Several critical drugs rely on the subcutaneous route for safe, steady therapeutic effects. Insulin is the most frequent example, managing blood glucose through various onset profiles. Anticoagulants like enoxaparin prevent deep vein thrombosis post-surgery. Certain vaccines, such as the MMR or varicella, also utilize this pathway.
| Medication Class | Common Example | Typical Volume Limit |
|---|---|---|
| Insulins | Regular, Glargine | Up to 1.5 mL |
| Anticoagulants | Enoxaparin | Pre-filled syringe volume |
| Immunizations | Measles vaccine | 0.5 mL |
Volumes injected subcutaneously must remain small, typically under 1.0 to 1.5 mL in adults, to prevent painful tissue distension and sterile abscess formation.
Selecting proper equipment ensures the drug reaches the correct tissue layer without complication. Standard equipment includes a syringe matched to the dose volume, an alcohol swab, and gloves. Needle gauge typically ranges from 25 to 30, and length varies from 3/8 inch to 5/8 inch.
Executing a subcutaneous injection demands precision, aseptic technique, and confidence. First, verify the medication order and assess the chosen skin site for bruising, lesions, or scars. Perform hand hygiene and put on non-sterile gloves. Cleanse the site with an alcohol swab using a firm circular motion outward, letting it dry completely to prevent stinging.
Gently pinch the subcutaneous tissue fold between your thumb and forefinger. Insert the needle swiftly at a 45-degree or 90-degree angle, depending on needle length and subcutaneous fat depth. Once the needle is fully inserted, release the skin fold if pinching is required to prevent injecting into compressed muscle. Push the plunger slowly to deliver the medication, withdraw the needle smoothly at the same angle, and apply gentle pressure with a dry cotton ball without massaging.
Failing to rotate injection sites leads to lipohypertrophy—an accumulation of fatty deposits—or lipoatrophy, which is the loss of subcutaneous fat. Both conditions severely impair predictable insulin absorption, causing erratic blood glucose levels. Nurses must teach patients to systematically move across injection grids, keeping injections at least two inches apart from previous marks.
Other local complications include hematomas, sterile abscesses, and accidental intramuscular injection. If a patient experiences persistent induration, redness, or signs of localized infection, the site must be abandoned, and the finding documented promptly in the nursing care plan.